)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
SINTX Technologies
SINTX Technologies (SINT) investor relations material
SINTX Technologies Registration filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration filing summary25 Jun, 2026
Company overview and business model
Develops, manufactures, and commercializes advanced silicon nitride ceramics for biomedical, antipathogenic, and industrial applications, with a focus on medical devices and high-performance components.
Products include FDA-cleared spinal and orthopedic implants, antipathogenic powders for infection control, and precision-engineered ceramics for aerospace and electronics.
Operates a certified manufacturing facility in Salt Lake City, Utah, serving primarily U.S. markets.
Financial performance and metrics
As of June 22, 2026, 6,357,630 shares of common stock were outstanding.
Received approximately $3.8 million in gross proceeds from a 2025 warrant inducement.
Reported stockholders' equity of $904,000 as of March 31, 2026, below Nasdaq's minimum requirement.
Use of proceeds and capital allocation
Will not receive proceeds from the resale of shares by selling stockholders.
May receive up to $8.3 million in gross proceeds if all warrants are exercised for cash; proceeds will be used for working capital and general corporate purposes.
Management has broad discretion over use of any warrant exercise proceeds.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from SINTX Technologies
- Silicon nitride implants disrupt extremity care with infection resistance and rapid market adoption.SINT
LD Micro Invitational XVI15 Jun 2026 - Q1 2025 net loss was $2.3M, but cash nearly doubled as focus shifted to medical devices.SINTQ1 202512 Jun 2026
- FDA clearance, first product revenue, and cost reductions drive improved results.SINTQ3 202512 Jun 2026
- 2024 revenue rose 10% to $2.9M, but net loss increased to $11.0M amid restructuring.SINTQ4 202412 Jun 2026
- Annual meeting to vote on directors, auditor, compensation, and new equity plan.SINTProxy filing12 Jun 2026
- Revenue fell sharply as the company pivots to higher-margin medical devices, but liquidity risks persist.SINTQ4 202512 Jun 2026
- Q2 2024 saw revenue growth, narrowed losses, a reverse split, workforce cuts, and a $4.5M impairment.SINTQ2 202412 Jun 2026
- Shareholders will vote on director election, auditor, executive pay, and expanding the equity plan.SINTProxy filing12 Jun 2026
- Q3 2024 net loss widened due to a $4.5M impairment and workforce reduction amid a strategic review.SINTQ3 202412 Jun 2026
Next SINTX Technologies earnings date
Q2 202612 Aug, 2026
SINTX Technologies
Next SINTX Technologies earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage